I have localized itching at the site of my Nexplanon (etonogestrel) implant placed a little over a year ago; how should I manage it and when is removal indicated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Localized Itching at Nexplanon Implant Site After One Year

For localized itching at the Nexplanon site after one year of use, start with symptomatic treatment using oral antihistamines and cold compresses; if symptoms persist despite conservative management or worsen, removal is indicated as this likely represents a delayed-type hypersensitivity reaction to the implant components.

Initial Assessment and Differential Diagnosis

The timing of symptom onset—over a year after insertion—is consistent with delayed-type hypersensitivity reactions, which can develop at any time during implant use 1. While extremely rare, allergic reactions to Nexplanon components (including barium sulfate or the ethylene vinyl acetate copolymer) have been documented 2, 3.

Key diagnostic considerations:

  • Rule out infection first: Examine for signs of erythema, warmth, purulence, or systemic symptoms that would indicate implant site infection rather than hypersensitivity 1
  • Assess for local hypersensitivity: Look specifically for localized dermatitis, eczema, or urticaria confined to the implant site 1
  • Exclude trauma or mechanical irritation: Verify the implant hasn't migrated or become encapsulated in a way that causes mechanical irritation 4, 5

Conservative Management Approach

If examination reveals only localized itching without signs of infection or severe reaction:

  • Oral antihistamines are the first-line symptomatic treatment for localized itching and can be continued for several days 1
  • Cold compresses applied to the site may reduce local discomfort and itching 1
  • Avoid topical corticosteroids initially unless there is visible dermatitis, as the evidence for their efficacy in implant-related reactions is limited 1

Indications for Removal

Removal should be performed if:

  • Symptoms persist beyond 7-10 days despite conservative management with antihistamines 2, 3
  • Symptoms progressively worsen or spread beyond the immediate implant site 1
  • Signs of infection develop (warmth, erythema, purulence) requiring broad-spectrum antibiotics and surgical drainage 1
  • The patient develops systemic symptoms suggesting widespread hypersensitivity 1

The evidence strongly supports that removal is curative for hypersensitivity reactions: In documented cases of delayed-type hypersensitivity to Nexplanon, symptoms resolved completely within 72 hours of implant removal 2, 3.

Important Clinical Considerations

  • Contraceptive efficacy is NOT compromised by localized itching—this is purely a local tissue reaction and does not affect the implant's function 6
  • Backup contraception is needed immediately if removal is performed, as fertility returns rapidly after explantation 7
  • Alternative contraceptive counseling should be provided before removal, considering non-hormonal IUDs or other methods if hormonal implants are not tolerated 6
  • The implant remains effective through year 3 and potentially into year 4, so if symptoms resolve with conservative management, continuation is reasonable from an efficacy standpoint 6

Common Pitfalls to Avoid

  • Do not prescribe antibiotics empirically for localized itching without clear signs of infection—the reaction is immunologic, not infectious 1
  • Do not delay removal if conservative measures fail after 7-10 days, as prolonged hypersensitivity reactions can worsen and affect quality of life 2, 3
  • Do not confuse irregular bleeding (common with Nexplanon) with a local site reaction—these are separate issues 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Implant site Nexplanon reaction?

BMJ case reports, 2015

Research

[Safety profile of etonogestrel contraceptive implant (Nexplanon® and Implanon®) reported in France].

Journal de gynecologie, obstetrique et biologie de la reproduction, 2016

Guideline

Nexplanon Contraceptive Effectiveness and Duration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.